Evidence map›Paper›PMID 27792870›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2017

Phenome-Wide Association Study of Autoantibodies to Citrullinated and Noncitrullinated Epitopes in Rheumatoid Arthritis.

Katherine P Liao, Jeffrey A Sparks, Boris P Hejblum, I-Hsin Kuo, Jing Cui, Lauren J Lahey, Andrew Cagan, Vivian S Gainer, Weidong Liu, T Tony Cai and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Disorders of Fibrinogen and Fibrinolysis.Hematology/oncology clinics of North America · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Katherine P LiaoBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Jeffrey A SparksBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-5556-4618
Boris P HejblumHarvard T. H. Chan School of Public Health, Boston, Massachusetts.
I-Hsin KuoBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and Biogen, Cambridge, Massachusetts.
Jing CuiBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Lauren J LaheyVA Palo Alto Healthcare System and Stanford University School of Medicine, Palo Alto, California.
Andrew CaganPartners Healthcare, Charlestown, Massachusetts.
Vivian S GainerPartners Healthcare, Charlestown, Massachusetts.
Weidong LiuShanghai Jiao Tong University, Shanghai, China.
T Tony CaiThe Wharton School, University of Pennsylvania, Philadelphia.
Jeremy SokoloveVA Palo Alto Healthcare System and Stanford University School of Medicine, Palo Alto, California.
Tianxi CaiHarvard T. H. Chan School of Public Health, Boston, Massachusetts.
Brigham and Women's Hospital · USHarvard University · USMass General Brigham · USVA Palo Alto Health Care System · USShanghai Jiao Tong University · CN

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
TrainingU54HG007963 · NHGRI · HARVARD MEDICAL SCHOOL · PI KOHANE, ISAAC S., MURPHY, SHAWN N · 2014 to 2018
$18.3M
Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid ArthritisR01HL127118 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIAO, KATHERINE PHOENIX · 2016 to 2020
$4.1M
Methods for genomic data with graphical structuresR01CA127334 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LEE, HONGZHE · 2007 to 2016
$2.6M
Rheumatoid Arthritis and Respiratory Outcomes in Prospective CohortsK23AR069688 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SPARKS, JEFFREY ANDREW · 2016 to 2020
$766k
Genetic Risk Factors for Coronary Artery Disease in Rheumatoid ArthritisK08AR060257 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LIAO, KATHERINE PHOENIX · 2011 to 2015
$649k
NCATS NIH HHS UL1 TR001102NCI NIH HHS R01 CA127334NHGRI NIH HHS U54 HG007963NHLBI NIH HHS R01 HL127118NIAMS NIH HHS K08 AR060257NIAMS NIH HHS K23 AR069688NIAMS NIH HHS L30 AR057693NIAMS NIH HHS L30 AR066953NIAMS NIH HHS P30 AR070253
6 · The paper itself

Abstract

objectivePatients with rheumatoid arthritis (RA) develop autoantibodies against a spectrum of antigens, but the clinical significance of these autoantibodies is unclear. Using a phenome-wide association study (PheWAS) approach, we examined the association between autoantibodies and clinical subphenotypes of RA.

methodsThis study was conducted in a cohort of RA patients identified from the electronic medical records (EMRs) of 2 tertiary care centers. Using a published multiplex bead assay, we measured 36 autoantibodies targeting epitopes implicated in RA. We extracted all International Classification of Diseases, Ninth Revision (ICD-9) codes for each subject and grouped them into disease categories (PheWAS codes), using a published method. We tested for the association of each autoantibody (grouped by the targeted protein) with PheWAS codes. To determine significant associations (at a false discovery rate [FDR] of ≤0.1), we reviewed the medical records of 50 patients with each PheWAS code to determine positive predictive values (PPVs).

resultsWe studied 1,006 RA patients; the mean ± SD age of the patients was 61.0 ± 12.9 years, and 79.0% were female. A total of 3,568 unique ICD-9 codes were grouped into 625 PheWAS codes; the 206 PheWAS codes with a prevalence of ≥3% were studied. Using the PheWAS method, we identified 24 significant associations of autoantibodies to epitopes at an FDR of ≤0.1. The associations that were strongest and had the highest PPV for the PheWAS code were autoantibodies against fibronectin and obesity (P = 6.1 × 10

conclusionWe demonstrated application of a bioinformatics method, the PheWAS, to screen for the clinical significance of RA-related autoantibodies. Using the PheWAS approach, we identified potentially significant links between variations in the levels of autoantibodies and comorbidities of interest in RA.

Indexed as

EpitopesArthritis, RheumatoidAutoantibodiesFemaleGenome-Wide Association StudyHumansMaleMiddle AgedPeptides, CyclicPhenotypeAutoantibodiescyclic citrullinated peptideEpitopesPeptides, Cyclic

Identifiers

PMID27792870
PMCPMC5378622
OpenAlexW2551682144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.